Table 4 Potential microRNA (miRNA)?mRNA interactions deregulated in the multiple myeloma (MM) with monosomy 13 as a unique abnormality

Supplementary table 2: List of miRNA target genes which were significantly deregulated in the MM with t(14;16) and whose expression level was inversely correlated with the miRNA expression.

Table 2. Deregulated microRNAs (miRNAs) in each of the cytogenetic groups in comparison with normal plasma cell (NPC); all the miRNAs were downregulated except for miR-1  miR-449 and miR-133a  which were upregulated in multiple myeloma (MM) with t(14;16).

Table 4. Top 30 over-expressed protein-coding genes in MSC from UC

Table 5. Top 30 over-expressed protein-coding genes in MSC from UCB

Supplementary Table 4: Genes identified as being consistently aberrantly methylated across different subtypes of AML

Table 3. Genes with a significant difference in variance between NF and CAF

Table 2. Genes down-regulated in CAF compared with NF

Table 1. Genes up-regulated in CAF compared with NF

Table 3. Genes up-regulated in CD4+ T cells from cord blood samples 1 and 2 (CB 1 and CB 2  respectively)

Table 4. Genes upregulated in CD4+T cells from peripheral blood (PB)

Table 4. Association of miR expression with survival of SQ for the five miRs included in the risk prediction model

SuppTable 9c: MicroRNAs associated with mortality risk for adenocarcinoma (All stages global p=0.27; early stages global p=0.20 for unadjusted analyses)

SuppTable 9a: MicroRNAs associated with mortality risk for adenocarcinoma (All stages global p=0.27; early stages global p=0.20 for unadjusted analyses)

SuppTable 9b: MicroRNAs associated with mortality risk for adenocarcinoma (All stages global p=0.27; early stages global p=0.20 for unadjusted analyses)

SuppTable 4: Correlation of miR expression and mRNA expression of predicted target genes for miRs differentiating adenocarcinoma from squamous cell carcinoma tissue samples

SuppTable 10: MicroRNAs associated with mortality risk for squamous cell carcinoma